REG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5 (b) - AbbVie Inc
RNS Number : 9788LBank of America Merrill Lynch05 May 2020FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT
RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNIZED INTERMEDIARY
STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
1.
KEY INFORMATION
Name of exempt principal trader
BofA Securities, Inc.
Company dealt in
AbbVie Inc
Class of relevant security to which the
dealings being disclosed relate(Note 1)Common - US00287Y1091
Date of dealing
04/05/2020
2.
INTERESTS AND SHORT POSITIONS
(a)
Interests and short positions (following dealing) in the class of relevant security
dealt in (Note 2)
Class of relevant security: Common
US00287Y1091
Long
Short
Number
%
Number
%
(1)
Relevant securities
205,279
0.014%
3,446,602
0.233 %
(2)
Derivatives (other than options):
2,506,285
0.17%
193,930
0.013%
(3)
Options and agreements to purchase/sell:
7,400
0.001%
7,500
0.001%
Total
2,718,964
0.184%
3,648,032
0.247%
(b)
Interests and short positions in relevant securities of the company, other than the
class dealt in (Note 2)
Class of relevant security:
Long
Short
Number
%
Number
%
(1)
Relevant securities
0
0%
0
0%
(2)
Derivatives (other than options):
0
0%
0
0%
(3)
Options and agreements to purchase/sell:
0
0%
0
0%
Total
0
0%
0
0%
3.
DEALINGS (Note 3)
(a)
Purchases and sales
Purchase/sale
Number of relevant securities
Price per unit (Note 4)
Purchase
1,470
81.86 USD
Purchase
1
81.34 USD
Purchase
2
81.36 USD
Purchase
2
81.38 USD
Purchase
1
81.4 USD
Purchase
1
81.44 USD
Purchase
1
81.45 USD
Purchase
201
81.46 USD
Purchase
474
81.47 USD
Purchase
887
81.48 USD
Purchase
2,056
81.49 USD
Purchase
100
81.5 USD
Purchase
231
81.52 USD
Purchase
24
81.53 USD
Purchase
65
81.54 USD
Purchase
286
81.55 USD
Purchase
2
81.57 USD
Purchase
4
81.6 USD
Purchase
1,000
81.627 USD
Purchase
86
81.65 USD
Purchase
101
81.66 USD
Purchase
1
81.71 USD
Purchase
99
81.73 USD
Purchase
1
81.74 USD
Purchase
101
81.76 USD
Purchase
218
81.77 USD
Purchase
169
81.78 USD
Purchase
1
81.79 USD
Purchase
482
81.8 USD
Purchase
92
81.81 USD
Purchase
71
81.82 USD
Purchase
123
81.83 USD
Purchase
101
81.84 USD
Purchase
3
81.85 USD
Purchase
3,452
81.86 USD
Purchase
2
81.87 USD
Purchase
40
81.9 USD
Purchase
1
81.91 USD
Purchase
19
81.92 USD
Purchase
18
81.94 USD
Purchase
61
81.95 USD
Purchase
87
81.96 USD
Purchase
17
81.965 USD
Purchase
186
81.97 USD
Purchase
256
81.98 USD
Purchase
2
82 USD
Purchase
229
82.01 USD
Purchase
16
82.02 USD
Purchase
1
82.09 USD
Purchase
100
82.17 USD
Purchase
2
82.24 USD
Purchase
1
82.29 USD
Purchase
1
82.36 USD
Purchase
18
82.84 USD
Purchase/sale
Number of relevant securities
Price per unit (Note 4)
Sale
30
81.19 USD
Sale
169
81.22 USD
Sale
5
81.23 USD
Sale
4
81.24 USD
Sale
121
81.25 USD
Sale
68
81.26 USD
Sale
375
81.27 USD
Sale
271
81.28 USD
Sale
344
81.29 USD
Sale
222
81.3 USD
Sale
24
81.31 USD
Sale
18
81.32 USD
Sale
285
81.33 USD
Sale
431
81.35 USD
Sale
99
81.36 USD
Sale
49
81.37 USD
Sale
52
81.38 USD
Sale
26
81.39 USD
Sale
105
81.4 USD
Sale
72
81.401 USD
Sale
100
81.42 USD
Sale
1
81.43 USD
Sale
177
81.44 USD
Sale
1
81.45 USD
Sale
110
81.46 USD
Sale
123
81.47 USD
Sale
314
81.48 USD
Sale
2,088
81.49 USD
Sale
230
81.5 USD
Sale
327
81.51 USD
Sale
526
81.52 USD
Sale
57
81.525 USD
Sale
34
81.53 USD
Sale
591
81.54 USD
Sale
1,050
81.55 USD
Sale
23
81.555 USD
Sale
234
81.56 USD
Sale
606
81.57 USD
Sale
245
81.575 USD
Sale
155
81.58 USD
Sale
4
81.585 USD
Sale
397
81.59 USD
Sale
260
81.595 USD
Sale
409
81.6 USD
Sale
5
81.605 USD
Sale
1,071
81.61 USD
Sale
2,110
81.62 USD
Sale
86
81.625 USD
Sale
960
81.63 USD
Sale
443
81.64 USD
Sale
315
81.65 USD
Sale
200
81.66 USD
Sale
316
81.67 USD
Sale
694
81.68 USD
Sale
100
81.69 USD
Sale
717
81.7 USD
Sale
1
81.705 USD
Sale
254
81.71 USD
Sale
149
81.72 USD
Sale
138
81.725 USD
Sale
5
81.73 USD
Sale
394
81.74 USD
Sale
518
81.75 USD
Sale
213
81.76 USD
Sale
607
81.77 USD
Sale
1,066
81.78 USD
Sale
986
81.79 USD
Sale
1,540
81.8 USD
Sale
612
81.81 USD
Sale
271
81.82 USD
Sale
230
81.83 USD
Sale
308
81.84 USD
Sale
67
81.85 USD
Sale
4
81.855 USD
Sale
1,032
81.86 USD
Sale
1
81.87 USD
Sale
711
81.88 USD
Sale
85
81.885 USD
Sale
480
81.89 USD
Sale
88
81.895 USD
Sale
278
81.9 USD
Sale
145
81.91 USD
Sale
267
81.92 USD
Sale
610
81.93 USD
Sale
343
81.94 USD
Sale
144
81.95 USD
Sale
269
81.96 USD
Sale
158
81.97 USD
Sale
1
81.975 USD
Sale
55
81.98 USD
Sale
15
81.99 USD
Sale
5
82 USD
Sale
268
82.01 USD
Sale
34
82.02 USD
Sale
57
82.03 USD
Sale
3
82.06 USD
Sale
34
82.07 USD
Sale
11
82.08 USD
Sale
1
82.12 USD
Sale
13
82.13 USD
Sale
4
82.14 USD
Sale
3
82.15 USD
Sale
11
82.16 USD
Sale
187
82.17 USD
Sale
12
82.18 USD
Sale
1
82.19 USD
Sale
86
82.26 USD
Sale
40
82.27 USD
Sale
209
82.28 USD
Sale
63
82.29 USD
Sale
36
82.31 USD
Sale
91
82.34 USD
Sale
43
82.35 USD
Sale
168
82.36 USD
Sale
2
82.37 USD
Sale
31
82.38 USD
Sale
86
82.46 USD
Sale
4
82.49 USD
Sale
87
82.5 USD
Sale
44
82.65 USD
Sale
113
82.66 USD
Sale
189
82.67 USD
Sale
171
82.68 USD
Sale
70
82.69 USD
Sale
100
82.7 USD
Sale
85
82.71 USD
Sale
174
82.72 USD
Sale
72
82.721 USD
Sale
457
82.73 USD
Sale
469
82.74 USD
Sale
740
82.75 USD
Sale
259
82.76 USD
Sale
272
82.77 USD
Sale
89
82.78 USD
Sale
86
82.79 USD
Sale
85
82.8 USD
Sale
18
82.84 USD
Sale
341
81.856 USD
(b)
Derivatives transactions (other than options transactions)
Product name,
e.g. CFDNature of transaction
(Note 5)Number of relevant securities
(Note 6)Price per unit
(Note 4)Swaps
Closing a Short Position
113
81.724 USD
Swaps
Increasing a Short Position
620
81.802 USD
Swaps
Reducing a Short Position
25
81.723 USD
Swaps
Reducing a Long Position
1,000
81.627 USD
(c)
Options transactions in respect of existing relevant securities
(i)
Writing, selling, purchasing or varying
Product name, e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise price
Type, e.g. American, European etc
Expiry date
Option money paid/ received per unit (Note 4)
N/A
N/A
N/A
N/A
N/A
N/A
N/A
(ii)
Exercising
Product name,
e.g. call optionNumber of securities
Exercise price per
unit (Note 4)N/A
N/A
N/A
(d)
Other dealings (including transactions in respect of new securities) (Note 3)
Nature or transaction
(Note 7)Details
Price per unit
(if applicable) (Note 4)
Borrow
Borrow of 339,600 shares
N/A
4.
OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting rights
or future acquisition or disposal of any relevant securities to which any derivative
referred to on this form is referenced. If none, this should be stated.None
Is a Supplemental Form 38.5(b) attached? (Note 8)
Yes
Date of disclosure
05/05/2020
Contact name
Tolu Tade
Telephone number
+44207 996 3410
Name of offeree/offeror with which connected
AbbVie Inc
Nature of connection (Note 9)
Advisor to - AbbVie Inc
SUPPLEMENTAL FORM 38.5(b)
DISCLOSURE UNDER RULE 38.5 (b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
Product name,
e.g. call optionWritten or
purchasedNumber of securities to which the option or derivative relates
Exercise price
(Note 2)Type, e.g.
American,
European etcExpiry date
Call Option
Written
7,500
105 USD
American
15/01/2021
Call Option
Purchased
7,400
85 USD
American
15/01/2021
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDISEBELFBBELLBBQ
Recent news on Abbvie
See all newsRCS - Ripple Therapeutics - Ripple Therapeutics Announces Collaboration
AnnouncementREG - Stock Exch Notice - Admission to ISM - 20/06/2024
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
Announcement